CELG.RT
Bristol-Myers Squibb Company Contingent Value Rights
CELG.RT
CELG.RT
21 hedge funds and large institutions have $56.3K invested in Bristol-Myers Squibb Company Contingent Value Rights in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
Holders
21
Holders Change
+1
Holders Change %
+5%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$336 |
| 2 |
2
Raymond James Financial
St Petersburg,
Florida
|
$1 |
| 3 |
FPF
3
First Pacific Financial
Vancouver,
Washington
|
$1 |
Top Sellers
| 1 |
TSS
1
Two Sigma Securities
New York
|
$550 |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$885 |
